531 related articles for article (PubMed ID: 25468311)
1. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
[TBL] [Abstract][Full Text] [Related]
5. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
[TBL] [Abstract][Full Text] [Related]
6. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
8. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
[TBL] [Abstract][Full Text] [Related]
9. Relationship between peripheral artery disease and combined albuminuria and low estimated glomerular filtration rate among elderly patients with type 2 diabetes mellitus.
Yap YS; Chuang HY; Chien CM; Tai YK
Diab Vasc Dis Res; 2014 Jan; 11(1):41-7. PubMed ID: 24227538
[TBL] [Abstract][Full Text] [Related]
10. Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease.
Ciobanu DM; Olar LE; Stefan R; Veresiu IA; Bala CG; Mircea PA; Roman G
J Diabetes Complications; 2015; 29(7):893-7. PubMed ID: 26169772
[TBL] [Abstract][Full Text] [Related]
11. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
[TBL] [Abstract][Full Text] [Related]
12. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
[TBL] [Abstract][Full Text] [Related]
13. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
[TBL] [Abstract][Full Text] [Related]
16. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
[TBL] [Abstract][Full Text] [Related]
17. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
[TBL] [Abstract][Full Text] [Related]
18. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
[TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Katoh T; Miyata T; Watanabe T
Nephrol Dial Transplant; 2011 Jan; 26(1):214-20. PubMed ID: 20591816
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
